You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Bambusa Therapeutics, Inc. filed an amended and restated certificate of incorporation and adopted amended and restated bylaws on November 2, 2026, following completion of its initial public offering.
Bambusa Therapeutics, Inc. is offering 9,375,000 common shares at an expected $15.00 to $17.00 per share and applied to list them on Nasdaq Global Select Market under “BBTX,” with closing contingent on listing.
Bambusa Therapeutics, Inc. is pursuing an initial public offering of common stock and applied to list on the Nasdaq Global Select Market under “BBTX,” subject to Nasdaq approval and an effective registration statement.
